5-methoxy MET
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 463672

CAS#: 16977-53-0

Description: 5-methoxy MET is an analytical reference standard categorized as a tryptamine. This product is intended for research and forensic applications.


Chemical Structure

img
5-methoxy MET
CAS# 16977-53-0

Theoretical Analysis

MedKoo Cat#: 463672
Name: 5-methoxy MET
CAS#: 16977-53-0
Chemical Formula: C14H20N2O
Exact Mass: 232.1576
Molecular Weight: 232.327
Elemental Analysis: C, 72.38; H, 8.68; N, 12.06; O, 6.89

Price and Availability

Size Price Availability Quantity
1.0mg USD 350.0 2 Weeks
5.0mg USD 950.0 2 Weeks
Bulk inquiry

Synonym: 5-methoxy MET; 5-methoxy-MET; 5 methoxy MET; 5 methoxy-MET; 5-Methoxy-N-methyl-N-ethyl-tryptamine;

IUPAC/Chemical Name: N-ethyl-2-(5-methoxy-1H-indol-3-yl)-N-methylethan-1-amine

InChi Key: AVECDEWGCOLCPZ-UHFFFAOYSA-N

InChi Code: InChI=1S/C14H20N2O/c1-4-16(2)8-7-11-10-15-14-6-5-12(17-3)9-13(11)14/h5-6,9-10,15H,4,7-8H2,1-3H3

SMILES Code: CN(CCC1=CNC2=CC=C(C=C21)OC)CC

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 232.327 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Grafinger KE, Wilke A, König S, Weinmann W. Investigating the ability of the microbial model Cunninghamella elegans for the metabolism of synthetic tryptamines. Drug Test Anal. 2019 May;11(5):721-729. doi: 10.1002/dta.2544. Epub 2018 Dec 25. PMID: 30462883.

2: Bocheva A, Nocheva H, Pavlov N, Todorov P, Calmès M, Martinez J, Naydenova E. Synthesis and analgesic effects of novel β2-tryptophan hexapeptide analogs. Amino Acids. 2013 Oct;45(4):983-8. doi: 10.1007/s00726-013-1555-4. Epub 2013 Jul 13. PMID: 23851698.

3: Jin MJ, Jin C, Kim JY, In MK, Kwon OS, Yoo HH. A quantitative method for simultaneous determination of 5-methoxy-N,N-diisopropyltryptamine and its metabolites in urine using liquid chromatography-electrospray ionization-tandem mass spectrometry. J Forensic Sci. 2011 Jul;56(4):1044-8. doi: 10.1111/j.1556-4029.2011.01753.x. Epub 2011 Mar 21. PMID: 21418218.

4: Guessous F, Daran JC, Viossat B, Morgant G, Labouze X, Leroy AL, Roch- Arveiller M, Dung NH. Ternary Copper(II) Complexes With Indomethacin, a Potent Non-Steroidal Antiinflammatory Drug. Crystal Structure of Bis (Dimethylformamide )-Tetrakis[1-(4-Chlorobenzoyl)-5-Methoxy-2-Methyl-1-H-Indole-3-Acetato]Dicopper( II). Antiinflammatory Properties and Prevention of Gastrointestinal Side Effects by Nanocapsules. Met Based Drugs. 1998;5(6):337-45. doi: 10.1155/MBD.1998.337. PMID: 18475870; PMCID: PMC2365144.

5: Winter JC, Helsley S, Fiorella D, Rabin RA. The acute effects of monoamine reuptake inhibitors on the stimulus effects of hallucinogens. Pharmacol Biochem Behav. 1999 Jul;63(3):507-13. doi: 10.1016/s0091-3057(99)00039-8. PMID: 10418794.

6: Meinnel T, Patiny L, Ragusa S, Blanquet S. Design and synthesis of substrate analogue inhibitors of peptide deformylase. Biochemistry. 1999 Apr 6;38(14):4287-95. doi: 10.1021/bi982622r. PMID: 10194346.

7: Wright CD, Stewart SF, Kuipers PJ, Hoffman MD, Thueson DO, Conroy MC. Inhibition of human neutrophil activation by the allergic mediator release inhibitor, CI-949. J Leukoc Biol. 1991 Jan;49(1):58-64. doi: 10.1002/jlb.49.1.58. PMID: 1845811.

8: Adolph AR. Pharmacological actions of peptides and indoleamines on turtle retinal ganglion cells. Vis Neurosci. 1989 Nov;3(5):411-23. doi: 10.1017/s0952523800005915. PMID: 2577268.

9: Uebelhack R, Franke L, Seidel K. Methylierte und nichtmethylierte Indolamine im zisternalen Liquor bei akuten endogenen Psychosen [Methylated and unmethylated indolamine in the cisternal fluid in acute endogenous psychoses]. Biomed Biochim Acta. 1983;42(10):1343-6. German. PMID: 6144308.